Pegcetacoplan

Pegcetacoplan (brand name: Evkeeza) is a prescription medicine used to treat adults with a rare blood disorder called paroxysmal nocturnal hemoglobinuria (PNH). It is a C3 inhibitor, which means it works by blocking the action of an enzyme called C3 convertase that helps to activate the complement system. This reduces certain proteins in the blood that can trigger red blood cell destruction. Pegcetacoplan is given by injection under the skin (subcutaneous) once a week.

Pegcetacoplan is a medication used to treat two distinct conditions:

1. Paroxysmal Nocturnal Hemoglobinuria (PNH): This is a rare blood disorder where red blood cells are abnormally broken down by the immune system [1, 2, 4].
2. Geographic Atrophy (GA) secondary to Age-Related Macular Degeneration (AMD): This is an eye disease that causes progressive vision loss due to deterioration of the macula, the central part of the retina responsible for sharp central vision [3, 5].

Here's a closer look at how Pegcetacoplan works for each condition:

• For PNH: Pegcetacoplan acts as a complement inhibitor [1, 2, 4]. The complement system is a part of the immune system that normally helps fight infections. However, in PNH, the complement system mistakenly attacks healthy red blood cells, causing them to break down. Pegcetacoplan blocks a specific protein (C3) in the complement cascade, preventing this attack and protecting red blood cells from destruction.
• For GA secondary to AMD: The exact mechanism of action in AMD is still under investigation, but Pegcetacoplan is believed to work by inhibiting a pathway that contributes to inflammation and tissue degeneration in the macula [3, 5]. By regulating this pathway, Pegcetacoplan may help slow down the progression of GA and preserve vision.

Important Points to Remember:

• Pegcetacoplan is available under different brand names, including Empaveli for PNH and SYFOVRE for GA [1, 3].
• For PNH: Pegcetacoplan is administered subcutaneously (under the skin) typically twice a week [1, 2].
• For GA: Pegcetacoplan is given as an intravitreal injection (injection into the vitreous cavity of the eye) by a qualified ophthalmologist (eye doctor) [3, 5]. The frequency of injections depends on your doctor's recommendation.
• Pegcetacoplan is a relatively new medication, and long-term safety data is still being collected [1, 3].
• It's a prescription medication and should only be used under the supervision of a doctor specializing in treating PNH or AMD, depending on the condition being treated [1, 3].

Here are some additional things to consider about Pegcetacoplan:

• Side effects: Potential side effects can vary depending on the condition being treated and the route of administration.
  • For PNH: Common side effects may include injection site reactions, infections, diarrhea, abdominal pain, respiratory tract infection, viral infection, and fatigue [2].
  • For GA: Potential side effects may include eye pain, increased eye pressure, vitreous floaters (seeing spots or cobwebs in your vision), conjunctivitis (pink eye), and retinal detachment [3]. It's crucial to report any side effects to your doctor.
• Alternatives: There are other medications available for treating PNH and AMD. Your doctor will discuss the best option for you based on your specific situation [1, 3].